Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersInfectious Disease Physician in Chapel Hill, NC
NPI: 1033321021Primary Practice Location
UNC HOSPITALS
101 Manning Dr, Chapel Hill, NC
Primary Employer
UNC Faculty Physicians
uncmedicalcenter.org
HQ Phone
Get M.D. Christopher's Phone NumberMobile
Get M.D. Christopher's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 30 | 85 |
| 2 | 99223Initial hospital inpatient care, typically 70 minutes per day | 27 | 27 |
Authors: Lisa Hightow- Weidman
Journal: Clin Infect Dis
Authors: Greer Burkholder, Edward Cachay, Karla Perez-Goldberg, George Yendewa, Jimmy Ma, Mari Kitahata, Audrey Lloyd, Katerina Christopoulos
Journal: Open Forum Infect Dis
Publication Date: 2025-01-17
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
Authors: Rizwana Mohseni, James Krainson, Ruanne Barnabas, Rajesh Kunadharaju, Gary Herman, Gerard Acloque, Karen Vigil, Mary Marovich, Neil Stahl, Fernando Alvarado, Richard Perez Perez, Flonza Isa
Journal: N Engl J Med
Publication Date: 2021-10-06
Lead Sponsor: Emory University
Collaborators: National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of Mississippi Medical Center, University of North Carolina, Chapel Hill
Intervention / Treatment: OTHER: ePrEP
Lead Sponsor: University of Minnesota
Collaborators: National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: REGN10933 + REGN10987
